share_log

HC Wainwright & Co. Reiterates Buy on Atara Biotherapeutics, Maintains $28 Price Target

HC Wainwright & Co. Reiterates Buy on Atara Biotherapeutics, Maintains $28 Price Target

HC Wainwright & Co.重申買入Atara Biotherapeutics,維持28美元的目標價
Benzinga ·  2023/09/26 06:35

HC Wainwright & Co. reiterates Atara Biotherapeutics (NASDAQ:ATRA) with a Buy and maintains $28 price target.

HC Wainwright&Co.重申Atara BioTreateutics(納斯達克:ATRA)的買入,並維持28美元的目標價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論